Compound C inhibits the replication of feline coronavirus.
AMPK
Compound C
Feline coronavirus
Feline enteric coronavirus
Feline infectious peritonitis
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
30 Mar 2024
30 Mar 2024
Historique:
received:
29
11
2023
revised:
13
02
2024
accepted:
05
03
2024
medline:
19
3
2024
pubmed:
19
3
2024
entrez:
19
3
2024
Statut:
epublish
Résumé
Feline Coronavirus (FCoV) is a viral pathogen of cats and a highly contagious virus. Cats in a cattery can be infected by up to 100%, and even household cats are infected by 20-60%. Some strains of FCoV are known to induce a fatal disease in cats named Feline Infectious Peritonitis (FIP). However, no effective treatments are available. We demonstrated that compound C (dorsomorphin) can potentially inhibit feline coronavirus replication. Compound C treatment decreased the FCoV-induced plaque formation and cytopathic effect in FCoV-infected cells. Compound C treatment also significantly reduced the amount of viral RNA and viral protein in the cells in a dose-dependent manner. Our findings suggest that compound C is potentially useful for feline coronavirus-related diseases.
Identifiants
pubmed: 38500971
doi: 10.1016/j.heliyon.2024.e27641
pii: S2405-8440(24)03672-7
pmc: PMC10945263
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e27641Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.